The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation
- PMID: 28420753
- DOI: 10.1126/scisignal.aah4273
The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation
Abstract
Tumor progression locus 2 (TPL2; also known as MAP3K8) is a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) that phosphorylates the MAPK kinases MEK1 and MEK2 (MEK1/2), which, in turn, activate the MAPKs extracellular signal-regulated kinase 1 (ERK1) and ERK2 (ERK1/2) in macrophages stimulated through the interleukin-1 receptor (IL-1R), Toll-like receptors (TLRs), or the tumor necrosis factor receptor (TNFR). We describe a conserved and critical role for TPL2 in mediating the effector functions of neutrophils through the activation of the p38 MAPK signaling pathway. Gene expression profiling and functional studies of neutrophils and monocytes revealed a MEK1/2-independent branch point downstream of TPL2 in neutrophils. Biochemical analyses identified the MAPK kinases MEK3 and MEK6 and the MAPKs p38α and p38δ as downstream effectors of TPL2 in these cells. Genetic ablation of the catalytic activity of TPL2 or therapeutic intervention with a TPL2-specific inhibitor reduced the production of inflammatory mediators by neutrophils in response to stimulation with the TLR4 agonist lipopolysaccharide (LPS) in vitro, as well as in rodent models of inflammatory disease. Together, these data suggest that TPL2 is a drug target that activates not only MEK1/2-dependent but also MEK3/6-dependent signaling to promote inflammatory responses.
Copyright © 2017, American Association for the Advancement of Science.
Similar articles
-
TPL2 kinase action and control of inflammation.Pharmacol Res. 2018 Mar;129:188-193. doi: 10.1016/j.phrs.2017.11.031. Epub 2017 Nov 26. Pharmacol Res. 2018. PMID: 29183769 Review.
-
TPL2 meets p38MAPK: emergence of a novel positive feedback loop in inflammation.Biochem J. 2016 Oct 1;473(19):2995-9. doi: 10.1042/BCJ20160672C. Biochem J. 2016. PMID: 27679858
-
Sterile inflammation in acetaminophen-induced liver injury is mediated by Cot/tpl2.J Biol Chem. 2013 May 24;288(21):15342-51. doi: 10.1074/jbc.M112.439547. Epub 2013 Apr 9. J Biol Chem. 2013. PMID: 23572518 Free PMC article.
-
Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.Mol Immunol. 2007 Jul;44(15):3715-23. doi: 10.1016/j.molimm.2007.04.002. Epub 2007 May 15. Mol Immunol. 2007. PMID: 17507094
-
Tpl2 kinase signal transduction in inflammation and cancer.Cancer Lett. 2011 May 28;304(2):80-9. doi: 10.1016/j.canlet.2011.02.004. Epub 2011 Mar 5. Cancer Lett. 2011. PMID: 21377269 Review.
Cited by
-
Multi-omics analysis of naïve B cells of patients harboring the C104R mutation in TACI.Front Immunol. 2022 Aug 16;13:938240. doi: 10.3389/fimmu.2022.938240. eCollection 2022. Front Immunol. 2022. PMID: 36072607 Free PMC article.
-
Unravelling the Impact of the Genetic Variant rs1042058 within the TPL2 Risk Gene Locus on Molecular and Clinical Disease Course Patients with Inflammatory Bowel Disease.Cells. 2021 Dec 20;10(12):3589. doi: 10.3390/cells10123589. Cells. 2021. PMID: 34944097 Free PMC article.
-
ERK1/2 in immune signalling.Biochem Soc Trans. 2022 Oct 31;50(5):1341-1352. doi: 10.1042/BST20220271. Biochem Soc Trans. 2022. PMID: 36281999 Free PMC article. Review.
-
Elevated Protein Kinase A Activity in Stomach Mesenchyme Disrupts Mesenchymal-epithelial Crosstalk and Induces Preneoplasia.Cell Mol Gastroenterol Hepatol. 2022;14(3):643-668.e1. doi: 10.1016/j.jcmgh.2022.06.001. Epub 2022 Jun 9. Cell Mol Gastroenterol Hepatol. 2022. PMID: 35690337 Free PMC article.
-
Altered Sox9 and FGF signaling gene expression in Aga2 OI mice negatively affects linear growth.JCI Insight. 2023 Nov 8;8(21):e171984. doi: 10.1172/jci.insight.171984. JCI Insight. 2023. PMID: 37796615 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
